Likewise, mutations in GBA1, which encodes the enzyme glucocerebrosidase (GCase), are highly prevalent in individuals with PD and currently constitute the most important genetic risk factor, where 5–25% of patients have GBA1 mutations. The gene discussed is GBA1; the disease is Parkinson disease.